PRKAA2 and neoplasm: Metformin-induced activation of the AMPK pathway is able to reduce the tumor-promoting activity of insulin and inhibit mTOR, which is closely related to tumor cell proliferation, making metformin an intriguing molecule in cancer therapy [37,38].